4.1 Article

Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy

期刊

JOURNAL OF NEUROVIROLOGY
卷 15, 期 4, 页码 324-333

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/13550280902973960

关键词

ART; brain; brain MRI; deformation morphometry; HIV; segmentation

资金

  1. NIAAA NIH HHS [P01 AA011493-03, P01 AA011493] Funding Source: Medline
  2. NIBIB NIH HHS [R03 EB008136, R03 EB008136-01, R03 EB 008136] Funding Source: Medline
  3. NIMH NIH HHS [R01 MH065392, R01 MH065392-01, R01 MH65392] Funding Source: Medline

向作者/读者索取更多资源

Treatment with antiretroviral therapy (ART) has greatly reduced the incidence of dementia. The goal of this longitudinal study was to determine if there are ongoing macrostructural brain changes in human immunodeficiency virus-positive (HIV+) individuals treated with ART. To quantify brain structure, three-dimensional T1-weighted magnetic resonance imaging (MRI) scans were performed at baseline and again after 24 months in 39 HIV + patients on ART and 30 HIV- controls. Longitudinal changes in brain volume were measured using tissue segmentation within regions of interest and deformation morphometry. Measured by tissue segmentation, HIV + patients on ART had significantly (all P <. 05) greater rates of white matter volume loss than HIV- control individuals. Compared with controls, the subgroup of HIV+ individuals on ART with viral suppression also had significantly greater rates of white matter volume loss. Deformation morphometry confirmed these results with more specific spatial localization. Deformation morphometry also detected greater rates of gray matter and white matter loss in the subgroup of HIV+ individuals with detectable viral loads. These results provide evidence of ongoing brain volume loss in HIV+ individuals on stable ART, possibly suggesting ongoing cerebral injury. The presence of continuing injury raises the possibility that HIV+ individuals-even in the presence of viral suppression in the periphery-are at greater risk for future cognitive impairments and dementia and possibly faster cognitive decline. Therefore, HIV+ individuals on ART should be monitored for cognitive decline, and treatments that reduce ongoing neurological injury should be considered. Journal of NeuroVirology (2009) 15, 324-333.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

The gray matter structural connectome and its relationship to alcohol relapse: Reconnecting for recovery

Susanne G. Mueller, Dieter J. Meyerhoff

Summary: Alcohol use disorders (AUD) are associated with gray matter (GM) atrophy, particularly in the frontal lobes, which can impact GM loss in other regions and potentially influence drinking behavior and relapse. Studies show that GM connectivity plays a crucial role in understanding the patterns of GM loss in interconnected regions.

ADDICTION BIOLOGY (2021)

Article Substance Abuse

Medical Conditions Linked to Atherosclerosis Are Associated With Magnified Cortical Thinning in Individuals With Alcohol Use Disorders

Timothy C. Durazzo, Linh-Chi Nguyen, Dieter J. Meyerhoff

ALCOHOL AND ALCOHOLISM (2020)

Article Biochemistry & Molecular Biology

GABA concentrations in the anterior cingulate and dorsolateral prefrontal cortices: Associations with chronic cigarette smoking, neurocognition, and decision making

Timothy C. Durazzo, Dieter J. Meyerhoff

Summary: Chronic cigarette smoking is associated with regional metabolite abnormalities in the human brain, particularly affecting GABA levels in different cortical regions. Smokers had lower GABA levels in the right DLPFC compared to nonsmokers, and higher ACC GABA levels were correlated with better decision-making abilities and auditory-verbal learning in smokers. Longitudinal studies with more female participants are needed to determine if these metabolite abnormalities persist or normalize with smoking cessation.

ADDICTION BIOLOGY (2021)

Article Substance Abuse

Not All Is Lost for Relapsers: Relapsers With Low WHO Risk Drinking Levels and Complete Abstainers Have Comparable Regional Gray Matter Volumes

Dieter J. Meyerhoff, Timothy C. Durazzo

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Article Environmental Sciences

The Prevalence of Mild Cognitive Impairment in a Convenience Sample of 202 Gulf War Veterans

Linda L. Chao

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Psychiatry

Does an Over-Connected Visual Cortex Undermine Efforts to Stay Sober After Treatment for Alcohol Use Disorder?

Angela M. Muller, Dieter J. Meyerhoff

FRONTIERS IN PSYCHIATRY (2020)

Article Neurosciences

Maladaptive brain organization at 1 month into abstinence as an indicator for future relapse in patients with alcohol use disorder

Angela M. Muller, Dieter J. Meyerhoff

Summary: Abstinence and relapse are lifelong challenges for patients with AUD. The study revealed that successful recovery from AUD is not linked to regaining the brain organization found in non-drinking controls, but to a new brain configuration distinct from healthy controls. Resting-state fMRI offers valuable insights into neuroplastic adaptations associated with AUD treatment outcomes.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Article Neuroimaging

Age-dependent brain morphometry in Major Depressive disorder

Alison Myoraku, Adam Lang, Charles T. Taylor, R. Scott Mackin, Dieter J. Meyerhoff, Susanne Mueller, Irina A. Strigo, Duygu Tosun

Summary: The study found that differences in brain morphology between MDD patients and healthy controls are dependent on age and brain region, with significant age-by-group interactions in the lateral orbital frontal gyrus and insular subregions, making these regions potential targets for future longitudinal studies of MDD.

NEUROIMAGE-CLINICAL (2022)

Article Psychiatry

Substance-Specific and Shared Gray Matter Signatures in Alcohol, Opioid, and Polysubstance Use Disorder

Angela M. Muller, David L. Pennington, Dieter J. Meyerhoff

Summary: This study found that substance use disorder patients exhibit gray matter loss mainly in the frontal cortex, and the patterns of brain alterations may differ across different types of substance use disorders. These alterations are also associated with functional networks in the brain.

FRONTIERS IN PSYCHIATRY (2022)

Review Biochemistry & Molecular Biology

Brain metabolite alterations related to alcohol use: a meta-analysis of proton magnetic resonance spectroscopy studies

Anna E. Kirkland, Brittney D. Browning, ReJoyce Green, Lorenzo Leggio, Dieter J. Meyerhoff, Lindsay M. Squeglia

Summary: Alcohol misuse and alcohol use disorder have neurobiological consequences as shown by the meta-analysis of proton magnetic resonance spectroscopy studies. These studies reveal alterations in brain metabolite levels, indicating decreased neuronal and axonal viability as well as membrane alterations related to alcohol misuse. The differences in creatine-containing metabolite levels were also noted. This study provides valuable information for further investigation of treatments targeting the observed disturbances.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial

Anna E. E. Kirkland, Brittney D. D. Browning, ReJoyce Green, Helen Liu, Anna M. M. Maralit, Pamela L. L. Ferguson, Dieter J. J. Meyerhoff, James J. J. Prisciandaro, Robert Miranda Jr, Kathleen T. T. Brady, Rachel L. L. Tomko, Kevin M. M. Gray, Lindsay M. M. Squeglia

Summary: Current treatments for adolescent alcohol use disorder (AUD) are limited in their efficacy, so investigating pharmacotherapies as adjunctive treatments is crucial. N-acetylcysteine is a promising candidate due to its tolerability and ability to modulate neurotransmitter systems. This preliminary investigation found no significant differences in brain metabolite levels or alcohol use between N-acetylcysteine and placebo, possibly due to the young age and non-treatment seeking status of the participants.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Substance Abuse

Non-abstinent recovery in alcohol use disorder is associated with greater regional cortical volumes than heavy drinking

A. C. May, D. J. Meyerhoff, T. C. Durazzo

Summary: This study investigated differences in brain structures associated with varying levels of alcohol consumption among individuals with alcohol use disorder (AUD) after treatment. The findings suggest that individuals who consume low-risk levels of alcohol post-treatment have brain volumes more similar to abstainers, indicating that harm reduction may be a beneficial and attainable goal for some individuals seeking treatment for AUD.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Neuroimaging

Frontocerebellar gray matter plasticity in alcohol use disorder linked to abstinence

Angela M. Muller, Dieter J. Meyerhoff

Summary: The study found that alcohol use disorder is associated with brain-wide gray matter reduction, with particular impact on the frontocerebellar circuit. There were significant differences in gray matter volume in the frontocerebellar circuit between abstainers and future relapsers, with abstainers showing increased gray matter with abstinence. Additionally, both AUD groups showed global atrophy relative to controls at follow-up, with different recovery patterns observed.

NEUROIMAGE-CLINICAL (2021)

Meeting Abstract Substance Abuse

WHO SAYS STAYING ABSTINENT IS EASY? SUSTANTIAL RE-CONFIGURATION OF THE INTRINSIC WHOLE-BRAIN-NETWORK ARCHITECTURE IN ABSTAINERS

A. M. Muller, D. J. Meyerhoff

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Meeting Abstract Substance Abuse

AN OVER-CONNECTED VISUAL CORTEX MAY UNDERMINE INDIVIDUAL EFFORTS TO STAY ABSTINENT AFTER TREATMENT FOR ALCOHOL USE DISORDER

A. M. Muller, D. J. Meyerhoff

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

暂无数据